PMID- 19965984 OWN - NLM STAT- MEDLINE DCOM- 20100301 LR - 20211020 IS - 1522-1504 (Electronic) IS - 1040-0605 (Print) IS - 1040-0605 (Linking) VI - 298 IP - 2 DP - 2010 Feb TI - Targeted disruption of NF-kappaB1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling. PG - L197-209 LID - 10.1152/ajplung.00265.2009 [doi] AB - NF-kappaB-mediated proinflammatory response to cigarette smoke (CS) plays a pivotal role in the pathogenesis of chronic obstructive pulmonary disease (COPD). The heterodimer of RelA/p65-p50 (subunits of NF-kappaB) is involved in transactivation of NF-kappaB-dependent genes, but interestingly p50 has no transactivation domain. The endogenous role of p50 subunit, particularly in regulation of CS-mediated inflammation in vivo, is not known. We therefore hypothesized that p50 subunit plays a regulatory role on RelA/p65, and genetic ablation of p50 (p50(-/-)) leads to increased lung inflammation and lung destruction in response to CS exposure in mouse. To test this hypothesis, p50-knockout and wild-type (WT) mice were exposed to CS for 3 days to 6 mo, and inflammatory responses as well as air space enlargement were assessed. Lungs of p50-deficient mice showed augmented proinflammatory response to acute and chronic CS exposures as evidenced by increased inflammatory cell influx and proinflammatory mediators release such as monocyte chemoattractant protein-1 (MCP-1) and interferon-inducible protein-10 (IP-10) compared with WT mice. IKK2 inhibitor (IMD-0354), which reduces the nuclear translocation of RelA/p65, attenuated CS-mediated neutrophil influx in bronchoalveolar lavage fluid and cytokine (MCP-1 and IP-10) levels in lungs of WT but not in p50-deficient mice. Importantly, p50 deficiency resulted in increased phosphorylation (Ser276 and Ser536), acetylation (Lys310), and DNA binding activity of RelA/p65 in mouse lung, associated with increased chromatin remodeling evidenced by specific phosphoacetylation of histone H3 (Ser10/Lys9) and acetylation of H4 (Lys12) in response to CS exposure. Surprisingly, p50-null mice showed spontaneous air space enlargement, which was further increased after CS exposure compared with WT mice. Thus our data showed that p50 endogenously regulates the activity of RelA/p65 by decreasing its phosphoacetylation and DNA binding activity and specific histone modifications and that genetic ablation of p50 leads to air space enlargement in mouse. FAU - Rajendrasozhan, Saravanan AU - Rajendrasozhan S AD - Department of Environmental Medicine, Lung Biology and Disease Program, University of Rochester Medical Center, Rochester, New York , USA. FAU - Chung, Sangwoon AU - Chung S FAU - Sundar, Isaac K AU - Sundar IK FAU - Yao, Hongwei AU - Yao H FAU - Rahman, Irfan AU - Rahman I LA - eng GR - 1-R01-HL-097751-01/HL/NHLBI NIH HHS/United States GR - ES-01247/ES/NIEHS NIH HHS/United States GR - R01-HL-085613/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20091204 PL - United States TA - Am J Physiol Lung Cell Mol Physiol JT - American journal of physiology. Lung cellular and molecular physiology JID - 100901229 RN - 0 (I-kappa B Proteins) RN - 0 (NF-kappa B p50 Subunit) RN - 0 (NFKBIA protein, human) RN - 0 (Nfkbia protein, mouse) RN - 0 (Rela protein, mouse) RN - 0 (Smoke) RN - 0 (Transcription Factor RelA) RN - 139874-52-5 (NF-KappaB Inhibitor alpha) RN - EC 2.7.11.10 (I-kappa B Kinase) SB - IM MH - Animals MH - *Chromatin Assembly and Disassembly MH - Gene Targeting MH - Humans MH - I-kappa B Kinase/antagonists & inhibitors MH - I-kappa B Proteins/metabolism MH - Lung/cytology/immunology/metabolism/pathology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - NF-KappaB Inhibitor alpha MH - NF-kappa B p50 Subunit/genetics/*metabolism MH - Neutrophils/cytology/immunology MH - *Pneumonia/etiology/immunology/pathology MH - *Pulmonary Emphysema/etiology/immunology/pathology MH - Smoke/*adverse effects MH - Smoking/*adverse effects MH - Transcription Factor RelA/genetics/metabolism PMC - PMC2822556 EDAT- 2009/12/08 06:00 MHDA- 2010/03/02 06:00 PMCR- 2011/02/01 CRDT- 2009/12/08 06:00 PHST- 2009/12/08 06:00 [entrez] PHST- 2009/12/08 06:00 [pubmed] PHST- 2010/03/02 06:00 [medline] PHST- 2011/02/01 00:00 [pmc-release] AID - 00265.2009 [pii] AID - L-00265-2009 [pii] AID - 10.1152/ajplung.00265.2009 [doi] PST - ppublish SO - Am J Physiol Lung Cell Mol Physiol. 2010 Feb;298(2):L197-209. doi: 10.1152/ajplung.00265.2009. Epub 2009 Dec 4.